Therapy Areas: Devices
Orthocell gains approval for Remplir across US defence and veterans hospital networks
16 April 2026 - Australian regenerative medicine company Orthocell Limited (ASX: OCC) announced on Thursday that it has secured approval for its Remplir nerve repair device to be used across the Unite...
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
15 April 2026 - Medical device company QT Imaging Holdings Inc (Nasdaq:QTI) announced on Wednesday the launch of the QT Imaging-Olea Viewer, developed in collaboration with Olea Medical, a leader in a...
CS Analytical appoints director of Scientific Affairs
15 April 2026 - CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory focused on package and container testing for the pharmaceutical, biotechnology, and medical device in...
MedPal AI launches integrated health OS platform to drive scalable digital healthcare
8 April 2026 - AI-powered, integrated digital health company MedPal AI plc (AIM: MPAL) (FRA: Z1N) declared on Wednesday that it has launched its MedPal Health Operating System, a vertically integrated...
CenExel appoints Dr. Sy Pretorius as CEO
8 April 2026 - Clinical research site network CenExel Clinical Research announced on Tuesday the appointment of Dr. Sy Pretorius as chief executive officer, effective 1 May 2026.Dr. Pretorius succeeds...
QT Imaging launches next-generation breast imaging reconstruction software
1 April 2026 - Medical device company QT Imaging Holdings Inc (Nasdaq: QTI) announced on Wednesday that it has released version 4.5.0 of its breast imaging reconstruction software, delivering enhanced...